Furthermore, the univariate analysis indicated that disease-specific survival (DSS) and metastasis-free survival (MeFS) were negatively determined by aggressive pT status (T), the presence of nodal metastasis, higher histological grade, the presence of vascular invasion and perineural invasion, higher expression of CEBPD and VEGFA (Figure 7A,B,E,F) and higher microvascular density (Figure 7C,D,G,H) in UBUC and UTUC. The gene discussed is CEBPD; the disease is renal pelvis/ureter urothelial carcinoma.